That was a fluke I remember the day and the prior week.Don't know where we end up but as one keep posting we sure got many ongoing trials and if only one hits it going to be like hitting the jackpot on a slot machine.
The right news 2 bucks is very possible.I think most big investors are waiting to see what occurs with the Shire trial that supposed to end last part of April 2015 most likely be 45 to 60 days later before we know.
Elliot gave us a big key in the update.Shire has not identified any safety issues that would preclude further development of SHP622 for Friedrich's Ataxia.
Just really want to see some serious R/D capital investments into Intellect by big Pharma or institutional investors taking part ownership then this could be a serious biotech company.
I still say the CONJUMAB platform is worth more then the whole imho.
News 
Market Data 
Discover 
